Literature DB >> 7637006

The neurovirulent GDVII strain of Theiler's virus can replicate in glial cells.

J P Simas1, H Dyson, J K Fazakerley.   

Abstract

The distribution, spread, neuropathology, tropism, and persistence of the neurovirulent GDVII strain of Theiler's virus in the central nervous system (CNS) was investigated in mice susceptible and resistant to chronic demyelinating infection with TO strains. Following intracerebral inoculation, the virus spread rapidly to specific areas of the CNS. There were, however, specific structures in which infection was consistently undetectable. Virus spread both between adjacent cell bodies and along neuronal pathways. The distribution of the infection was dependent on the site of inoculation. The majority of viral RNA-positive cells were neurons. Many astrocytes were also positive. Infection of both of these cell types was lytic. In contrast, viral RNA-positive oligodendrocytes were rare and were observed only in well-established areas of infection. The majority of oligodendrocytes in these areas were viral RNA negative and were often the major cell type remaining; however, occasional destruction of these cells was observed. No differences in any of the above parameters were observed between CBA and BALB/c mice, susceptible and resistant, respectively, to chronic CNS demyelinating infection with TO strains of Theiler's virus. By using Southern blot hybridization to detect reverse-transcribed PCR-amplified viral RNA sequences, no virus persistence could be detected in the CNS of immunized mice surviving infection with GDVII. In conclusion, the GDVII strain of Theiler's murine encephalomyelitis virus cannot persist in the CNS, but this is not consequent upon an inability to infect glial cells, including oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637006      PMCID: PMC189416     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  A single amino acid change determines persistence of a chimeric Theiler's virus.

Authors:  N Jarousse; R A Grant; J M Hogle; L Zhang; A Senkowski; R P Roos; T Michiels; M Brahic; A McAllister
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

2.  The pathogenesis of Theiler's GD VII encephalomyelitis virus infection in mice as studied by immunofluorescent technique and infectivity titrations.

Authors:  C Liu; J Collins; E Sharp
Journal:  J Immunol       Date:  1967-01       Impact factor: 5.422

3.  Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease.

Authors:  Y Wada; M L Pierce; R S Fujinami
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

4.  FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus.

Authors:  A Azoulay; M Brahic; J F Bureau
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

5.  Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin.

Authors:  M Rodriguez; A J Dunkel; R L Thiemann; J Leibowitz; M Zijlstra; R Jaenisch
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

6.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.

Authors:  J Embretson; M Zupancic; J L Ribas; A Burke; P Racz; K Tenner-Racz; A T Haase
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

7.  Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons.

Authors:  J K Fazakerley; S Pathak; M Scallan; S Amor; H Dyson
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

8.  Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist.

Authors:  G Poli; A L Kinter; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

9.  Theiler's virus infection of beta 2-microglobulin-deficient mice.

Authors:  L Fiette; C Aubert; M Brahic; C P Rossi
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

10.  Upregulation of human immunodeficiency virus-1 in chronically infected monocytic cell line by both contact with endothelial cells and cytokines.

Authors:  S T Fan; K Hsia; T S Edgington
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more
  8 in total

1.  The GDVII strain of Theiler's virus spreads via axonal transport.

Authors:  C Martinat; N Jarousse; M C Prévost; M Brahic
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Epitope-tagged L* protein of Theiler's murine encephalomyelitis virus is expressed in the central nervous system in the acute phase of infection.

Authors:  Kunihiko Asakura; Harunobu Murayama; Toshiki Himeda; Yoshiro Ohara
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  The neurovirulence of the DA and GDVII strains of Theiler's virus correlates with their ability To infect cultured neurons.

Authors:  N Jarousse; S Syan; C Martinat; M Brahic
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

4.  The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system.

Authors:  M K Njenga; K Asakura; S F Hunter; P Wettstein; L R Pease; M Rodriguez
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Specific infection and destruction of dopaminergic neurons in the substantia nigra by Theiler's virus.

Authors:  K R Oliver; P Brennan; J K Fazakerley
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  Phylogenetic analysis of the species Theilovirus: emerging murine and human pathogens.

Authors:  Zhiguo Liang; A S Manoj Kumar; Morris S Jones; Nick J Knowles; Howard L Lipton
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

7.  Depletion of Olig2 in oligodendrocyte progenitor cells infected by Theiler's murine encephalomyelitis virus.

Authors:  Bayleigh Benner; Anthony J Martorell; Padmanabhan Mahadevan; Fadi J Najm; Paul J Tesar; Eric C Freundt
Journal:  J Neurovirol       Date:  2015-12-02       Impact factor: 2.643

Review 8.  Intrathecal humoral immunity to encephalitic RNA viruses.

Authors:  Timothy W Phares; Stephen A Stohlman; Cornelia C Bergmann
Journal:  Viruses       Date:  2013-02-15       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.